Obstructive sleep apnoea syndrome, plasma adiponectin levels, and insulin resistance
The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Summary: Objective To investigate whether sleep‐disordered breathing and/or plasma adiponectin levels are associated with insulin resistance independent of obesity or fat distribution in obstructive sleep apnoea syndrome (OSAS). Design Cross‐sectional clinical study. Patients Two‐hundred and thirteen Japanese patients with OSAS aged 27–80 years were divided into three groups: 30 with mild OSAS [apnoea–hypopnoea index (AHI) = 10·3 ± 0·9 episodes/h, minimum oxygen saturation (min SpO 2) = 87·3 ± 0·9%], 98 with moderate OSAS (AHI = 28·9 ± 0·6 episodes/h, min SpO 2 = 82·1 ± 0·7%), and 85 with severe OSAS (AHI = 68·1 ± 2·8 episodes/h, min SpO 2 = 72·3 ± 1·6%). Twenty‐one patients undergoing diabetic treatments (two mild, nine moderate and 10 severe) were excluded from the assessment of insulin resistance and plasma adiponectin measurements. Measurements Fat distribution [evaluated according to visceral (V) and subcutaneous (S) fat areas using computed tomography scanning at the umbilical level], blood pressure, metabolic parameters and hormones including insulin and adiponectin were measured. After full polysomnography, venous blood was collected between 0600 and 0700 h. Results Severe OSAS patients were more hypertensive than mild and moderate OSAS. Fasting plasma glucose (FPG) and fasting plasma insulin and homeostasis model assessment of insulin resistance (HOMA‐IR) levels were all higher in severe OSAS than mild and moderate OSAS patients. HOMA‐IR was correlated not only with obesity [body mass index (BMI), V and S areas] but also with apnoea (AHI, min SpO 2 and desaturation time). Additionally, HOMA‐IR was correlated positively with haemoglobin (Hb)A 1c, systolic (SBP) and diastolic blood pressure (DBP), triglycerides and free fatty acids (FFA), and negatively with high density lipoprotein (HDL)‐cholesterol, suggesting that insulin resistance is a key component of the metabolic syndrome in OSAS. Plasma adiponectin levels were not different between mild, moderate and severe OSAS groups. Plasma adiponectin levels were correlated with HOMA‐IR and V area, but not AHI or min SpO 2. Stepwise multiple regression analysis, however, revealed that BMI, AHI and plasma adiponectin were independently associated with HOMA‐IR. Conclusion Sleep‐disordered breathing was associated with insulin resistance independent of obesity. Although plasma adiponectin was also an independent determinant of HOMA‐IR in OSAS patients, plasma adiponectin was more closely related to obesity than to sleep apnoea. Although treatment of sleep‐disordered breathing with nasal continuous positive airway pressure reportedly improves insulin sensitivity, our findings suggest that treatment of obesity is also essential in ameliorating insulin resistance at least through increased plasma adiponectin levels in OSAS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) · Diabetes Care · doi:10.2337/diacare.20.7.1183 · Cited by 6,220
Prospective Study of the Association between Sleep-Disordered Breathing and Hypertension
Peppard, P. E., Young, T., Palta, M., & Skatrud, J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005113421901 · Cited by 4,973
Paradoxical Decrease of an Adipose-Specific Protein, Adiponectin, in Obesity
Arita, Y., Kihara, S., Ouchi, N., Takahashi, M., Maeda, K., Miyagawa, J.-I., Hotta, K., Shimomura, I., Nakamura, T., Miyaoka, K., et al. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0255 · Cited by 4,856
Weyer, C., Funahashi, T., Tanaka, S., Hotta, K., Matsuzawa, Y., Pratley, R. E., & Tataranni, P. A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.5.7463 · Cited by 3,541
Nieto, F. J. (2000) · JAMA · doi:10.1001/jama.283.14.1829 · Cited by 3,369
Sleep-disordered Breathing and Cardiovascular Disease
SHAHAR, E., WHITNEY, C. W., REDLINE, S., LEE, E. T., NEWMAN, A. B., JAVIER NIETO, F., O'CONNOR, G. T., BOLAND, L. L., SCHWARTZ, J. E., & SAMET, J. M. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.1.2001008 · Cited by 2,901
Hyperinsulinemia as an independent risk factor for ischemic heart disease
Després, J.-P., Lamarche, B., Mauriège, P., Cantin, B., Dagenais, G. R., Moorjani, S., & Lupien, P.-J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199604113341504 · Cited by 1,699
Obstructive Sleep Apnea Is Independently Associated with Insulin Resistance
Ip, M. S. M., Lam, B., Ng, M. M. T., Lam, W. K., Tsang, K. W. T., & Lam, K. S. L. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.5.2103001 · Cited by 1,300
Harsch, I. A., Schahin, S. P., Radespiel-Tröger, M., Weintz, O., Jahreiß, H., Fuchs, F. S., Wiest, G. H., Hahn, E. G., Lohmann, T., Konturek, P. C., et al. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200302-206oc · Cited by 583
Cited by
McNicholas, W. T., Bonsignore, M. R., & the Management Committee of EU COST ACTION B26 (2007) · European Respiratory Journal · doi:10.1183/09031936.00027406 · Cited by 911
Obstructive Sleep Apnea and Type 2 Diabetes
Tasali, E., Mokhlesi, B., & Van Cauter, E. (2008) · Chest · doi:10.1378/chest.07-0828 · Cited by 371
Obstructive sleep apnea and type 2 diabetes
Rasche, K., Keller, T., Tautz, B., Hader, C., Hergenç, G., Antosiewicz, J., Di Giulio, C., & Pokorski, M. (2010) · European Journal of Medical Research · doi:10.1186/2047-783x-15-s2-152 · Cited by 369
Garvey, J. F., Taylor, C. T., & McNicholas, W. T. (2009) · European Respiratory Journal · doi:10.1183/09031936.00111208 · Cited by 356
Molecular Signatures of Obstructive Sleep Apnea in Adults: A Review and Perspective
Arnardottir, E. S., Mackiewicz, M., Gislason, T., Teff, K. L., & Pack, A. I. (2009) · Sleep · doi:10.1093/sleep/32.4.447 · Cited by 345
Sleep, sleep-disordered breathing and metabolic consequences
Lévy, P., Bonsignore, M. R., & Eckel, J. (2009) · European Respiratory Journal · doi:10.1183/09031936.00166808 · Cited by 340
Sleep and Metabolism: An Overview
Sharma, S., & Kavuru, M. (2010) · International Journal of Endocrinology · doi:10.1155/2010/270832 · Cited by 272
Obesity, obstructive sleep apnoea and metabolic syndrome
LAM, J. C. M., MAK, J. C. W., & IP, M. S. M. (2012) · Respirology · doi:10.1111/j.1440-1843.2011.02081.x · Cited by 198
Yenigün, M. (2013) · Medical Science Monitor · doi:10.12659/msm.883776 · Cited by 109
“independent of body weight [6–11].”
Kelly, A., Dougherty, S., Cucchiara, A., Marcus, C. L., & Brooks, L. J. (2010) · SLEEP · doi:10.1093/sleep/33.9.1185 · Cited by 85
Neuroendocrine alterations in obese patients with sleep apnea syndrome
Lanfranco, F., Motta, G., Minetto, M. A., Baldi, M., Balbo, M., Ghigo, E., Arvat, E., & Maccario, M. (2010) · International Journal of Endocrinology · doi:10.1155/2010/474518 · Cited by 78
“between adiponectin concentrations and the severity of OSAS have been described by some [41, 42] but not by other authors [37] and nCPAP failed to increase adiponectin concentrations in obese patients with OSAS [43] (Table 1).”
Result
Metadata
- Authors
- Makino, S., Handa, H., Suzukawa, K., Fujiwara, M., Nakamura, M., Muraoka, S., Takasago, I., Tanaka, Y., Hashimoto, K., & Sugimoto, T.
- Venue
- Clinical Endocrinology
- Publisher
- Wiley
- Published
- 2005-11-18
- Volume
- 64
- Issue
- 1
- Pages
- 12-19
- ISSN
- 0300-0664 (ISSN-L)
- 1365-2265
- OpenAlex
- W2167811105
- Cited by
- 141
- References
- 13
- FWCI
- 4.93
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.